Literature DB >> 21415307

G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding.

Ivone Gomes1, Adriaan P Ijzerman, Kai Ye, Emeline L Maillet, Lakshmi A Devi.   

Abstract

It is becoming increasingly recognized that G protein-coupled receptors physically interact. These interactions may provide a mechanism for allosteric modulation of receptor function. In this study, we examined this possibility by using an established model system of a receptor heteromer consisting of μ and δ opioid receptors. We examined the effect of a number of μ receptor ligands on the binding equilibrium and association and dissociation kinetics of a radiolabeled δ receptor agonist, [(3)H]deltorphin II. We also examined the effect of δ receptor ligands on the binding equilibrium and association and dissociation kinetics of a radiolabeled μ receptor agonist, [(3)H][d-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin ([(3)H]DAMGO). We show that μ receptor ligands are capable of allosterically enhancing δ receptor radioligand binding and vice versa. Thus, there is strong positive cooperativity between the two receptor units with remarkable consequences for ligand pharmacology. We find that the data can be simulated by adapting an allosteric receptor model previously developed for small molecules, suggesting that the ligand-occupied protomers function as allosteric modulators of the partner receptor's activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21415307      PMCID: PMC3102551          DOI: 10.1124/mol.110.070847

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  33 in total

1.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy.

Authors:  I Gomes; B A Jordan; A Gupta; N Trapaidze; V Nagy; L A Devi
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 2.  G-protein-coupled receptor dimerization: modulation of receptor function.

Authors:  C D Rios; B A Jordan; I Gomes; L A Devi
Journal:  Pharmacol Ther       Date:  2001 Nov-Dec       Impact factor: 12.310

Review 3.  G protein-coupled receptor allosterism and complexing.

Authors:  Arthur Christopoulos; Terry Kenakin
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

4.  Opioid receptor oligomerization. Detection and functional characterization of interacting receptors.

Authors:  Ivone Gomes; Julija Filipovska; Lakshmi A Devi
Journal:  Methods Mol Med       Date:  2003

5.  Functional interactions between mu opioid and alpha 2A-adrenergic receptors.

Authors:  B A Jordan; I Gomes; C Rios; J Filipovska; L A Devi
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

6.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Authors:  Ivone Gomes; Achla Gupta; Julija Filipovska; Hazel H Szeto; John E Pintar; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

Review 7.  Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.

Authors:  Willem Soudijn; Ineke Van Wijngaarden; Ad P IJzerman
Journal:  Drug Discov Today       Date:  2004-09-01       Impact factor: 7.851

8.  An amino-acid taste receptor.

Authors:  Greg Nelson; Jayaram Chandrashekar; Mark A Hoon; Luxin Feng; Grace Zhao; Nicholas J P Ryba; Charles S Zuker
Journal:  Nature       Date:  2002-02-24       Impact factor: 49.962

9.  G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.

Authors:  Pierluigi Onali; Maria C Olianas
Journal:  Br J Pharmacol       Date:  2004-09-27       Impact factor: 8.739

Review 10.  Exploring a role for heteromerization in GPCR signalling specificity.

Authors:  Raphael Rozenfeld; Lakshmi A Devi
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

View more
  50 in total

1.  CXCR4 gene transfer prevents pressure overload induced heart failure.

Authors:  Thomas J Larocca; Dongtak Jeong; Erik Kohlbrenner; Ahyoung Lee; Jiqiu Chen; Roger J Hajjar; Sima T Tarzami
Journal:  J Mol Cell Cardiol       Date:  2012-06-03       Impact factor: 5.000

2.  Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity.

Authors:  Ivone Gomes; Wakako Fujita; Achla Gupta; S Adrian Saldanha; Adrian S Saldanha; Ana Negri; Christine E Pinello; Christina Eberhart; Edward Roberts; Marta Filizola; Peter Hodder; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

3.  Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A.

Authors:  Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

4.  The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.

Authors:  Shou-Pu Yi; Qing-Hong Kong; Yu-Lei Li; Chen-Ling Pan; Jie Yu; Ben-Qiang Cui; Ying-Fei Wang; Guan-Lin Wang; Pei-Lan Zhou; Li-Li Wang; Ze-Hui Gong; Rui-Bin Su; Yue-Hai Shen; Gang Yu; Kwen-Jen Chang
Journal:  Acta Pharmacol Sin       Date:  2017-05-15       Impact factor: 6.150

Review 5.  The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization.

Authors:  Graeme Milligan
Journal:  Mol Pharmacol       Date:  2013-04-30       Impact factor: 4.436

Review 6.  Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse.

Authors:  Ivone Gomes; Wakako Fujita; Moraje V Chandrakala; Lakshmi A Devi
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

Review 7.  G Protein-Coupled Receptor Heteromers.

Authors:  Ivone Gomes; Mohammed Akli Ayoub; Wakako Fujita; Werner C Jaeger; Kevin D G Pfleger; Lakshmi A Devi
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-22       Impact factor: 13.820

Review 8.  Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 9.  Challenges for opioid receptor nomenclature: IUPHAR Review 9.

Authors:  Brian M Cox; Macdonald J Christie; Lakshmi Devi; Lawrence Toll; John R Traynor
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

10.  GPR171 is a hypothalamic G protein-coupled receptor for BigLEN, a neuropeptide involved in feeding.

Authors:  Ivone Gomes; Dipendra K Aryal; Jonathan H Wardman; Achla Gupta; Khatuna Gagnidze; Ramona M Rodriguiz; Sanjai Kumar; William C Wetsel; John E Pintar; Lloyd D Fricker; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.